CytomX Therapeutics
CTMX
CTMX
70 hedge funds and large institutions have $48.1M invested in CytomX Therapeutics in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 10 closing their positions.
Holders
70
Holders Change
+1
Holders Change %
+1.45%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
24
Reduced
21
Closed
10
Calls
$36K
Puts
$5K
Net Calls
+$31K
Net Calls Change
-$102K
Top Buyers
| 1 |
1
Point72 Asset Management
Stamford,
Connecticut
|
$2.73M |
| 2 |
PM
2
Prosight Management
Dallas,
Texas
|
$4.02M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$836K |
| 4 |
4
Millennium Management
New York
|
$3.32M |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$524K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Invesco
Atlanta,
Georgia
| – | – | -37,464 | Closed |
|
77
Goldman Sachs
New York
| – | – | -12,000 | Closed |
|
|
EWA
78
EP Wealth Advisors
Torrance,
California
| – | – | -10,432 | Closed |
|
79
Federated Hermes
Pittsburgh,
Pennsylvania
| – | – | -117 | Closed |
|
|
CFGS
80
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
81
Squarepoint
New York
| – | – | – | – |
|
82
Simplex Trading
Chicago,
Illinois
| $0 | 507 | +507 | New |
|